Scarica l'app Stockscreener
38.37
3.42%
-1.36
Pre-mercato:
38.37
Precedente Chiudi:
$39.73
Aprire:
$39.3
Volume 24 ore:
1.18M
Relative Volume:
1.29
Capitalizzazione di mercato:
$1.98B
Reddito:
$412.82M
Utile/perdita netta:
$-8.19M
Rapporto P/E:
-248.99
EPS:
-0.1541
Flusso di cassa netto:
$64.17M
1 W Prestazione:
+33.41%
1M Prestazione:
+46.56%
6M Prestazione:
+89.95%
1 anno Prestazione:
+222.03%
Intervallo 1D:
$38.03
$39.84
Intervallo di 1 settimana:
$28.25
$40.47
Portata 52W:
$11.26
$40.47
Caredx Inc Stock (CDNA) Company Profile
Nome
Caredx Inc
Settore
Industria
Telefono
415-287-2300
Indirizzo
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, NTRA, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
38.37 | 1.98B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
526.23 | 195.56B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
201.11 | 142.34B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
563.81 | 44.48B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
262.63 | 37.61B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
130.26 | 36.79B | 7.23B | 1.41B | 1.09B | 4.979 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-06 | Downgrade | Craig Hallum | Buy → Hold |
| 2025-08-26 | Iniziato | William Blair | Mkt Perform |
| 2025-01-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Underweight |
| 2024-08-19 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-05-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2023-11-09 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-03-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Downgrade | Craig Hallum | Buy → Hold |
| 2023-03-03 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2021-07-20 | Ripresa | BTIG Research | Buy |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-02-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-02 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-26 | Iniziato | BTIG Research | Buy |
| 2020-06-19 | Reiterato | H.C. Wainwright | Buy |
| 2019-10-01 | Ripresa | Craig Hallum | Buy |
| 2019-05-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Iniziato | Jefferies | Buy |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-09-18 | Reiterato | H.C. Wainwright | Neutral |
| 2017-11-27 | Iniziato | H.C. Wainwright | Buy |
| 2016-06-14 | Reiterato | Mizuho | Buy |
| 2015-09-29 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Iniziato | Craig Hallum | Buy |
| 2015-03-18 | Reiterato | Mizuho | Buy |
Mostra tutto
Caredx Inc Borsa (CDNA) Ultime notizie
CareDx Inc (CDNA) Shares Fall 3.4% -- GF Value Says Still Overva - GuruFocus
CareDx shares jump as Medicare finalizes transplant testing coverage policy (CDNA) - MSN
CareDx Inc (CDNA) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
CareDx (CDNA) Q4 2025 earnings summary - Quartr
CareDx (CDNA) Proxy filing Summary - Quartr
CareDx (CDNA) Q3 2024 earnings summary - Quartr
CareDx’s Growth Prospects With Naveris Keep Me Bullish (NASDAQ:CDNA) - Seeking Alpha
CareDx (CDNA) Is Up 39.4% After Final Medicare Coverage Clarifies Transplant Test Reimbursement Limits - simplywall.st
CareDx (CDNA) Is Up 39.4% After Medicare Clarifies Transplant Test Coverage LimitsWhat's Changed - Yahoo Finance
CareDx (CDNA) Secures Medicare Reimbursement Clarity, Is The Upside Already Priced In? - Yahoo Finance
CareDx rallies after Medicare finalizes transplant testing coverage policy - MSN
Form 4 Caredx Inc For: 17 July By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Neutral stock rating on CareDx - Investing.com UK
CareDx director Hannah Valantine disposes of common shares worth $1.04 million - Bitget
H.C. Wainwright reiterates Neutral stock rating on CareDx By Investing.com - Investing.com Nigeria
CareDx CEO John Hanna sells $4.46m in company stock - Investing.com
CareDx CEO John Hanna sells $4.46m in company stock By Investing.com - Investing.com UK
[Form 4] CareDx, Inc. Insider Trading Activity - Stock Titan
CareDx (CDNA) director sells 28,779 shares and exercises options - Stock Titan
A Quick Look at Today's Ratings for CareDx(CDNA.US), With a Forecast Between $35 to $45 - Moomoo
Caredx Inc (CDNA) News, Articles, Events & Latest Updates - Stocktwits
CareDx (CDNA) Moves 35.6% Higher: Will This Strength Last? - Yahoo Finance
Why Is CareDx Stock Skyrocketing Thursday? - Sahm
BTIG raises CareDx stock price target to $45 on coverage decision - Investing.com UK
Form 144 CAREDX For: 16 July By Investing.com - Investing.com Nigeria
CareDx says final Medicare LCD maintains coverage for transplant rejection surveillance tests - Bitget
CareDx sets webcast to discuss second-quarter 2026 results after market close - Bitget
BTIG raises CareDx stock price target to $45 on coverage decision By Investing.com - Investing.com South Africa
Price to earnings forward of CareDx, Inc. – GETTEX:1K9 - TradingView
CareDx Inc. (CDNA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Form 144 | CareDx(CDNA.US) Director Proposes to Sell 3.51 Million in Common Stocks - Moomoo
CareDx (CDNA) Jumps As Naveris Deal Redraws Growth Map - timothysykes.com
CDNA (NASDAQ: CDNA) holder John Hanna files notice to sell 118,000 shares - Stock Titan
Planned 28,779-share CDNA (NASDAQ: CDNA) sale follows earlier 10b5-1 trade - Stock Titan
Caredx Inc stock hits 52-week high at 36.4 USD By Investing.com - Investing.com South Africa
CAREDX INC : BTIG RAISES TARGET PRICE TO $45 FROM $28 - Bitget
CDNA Maintained by BTIG -- Price Target Raised to $45 - GuruFocus
Caredx Inc stock hits 52-week high at 36.4 USD - Investing.com
CareDx to report Q2 2026 financial results on July 30 - scanx.trade
CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination - Finviz
CareDx (CDNA) Secures Medicare Coverage for Molecular Testing - GuruFocus
CareDx stock surges 20% on Medicare coverage policy By Investing.com - Investing.com India
CareDx stock surges 20% on Medicare coverage policy - Investing.com
Press Release: CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026 - Moomoo
CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026 - Business Wire
How Caredx Inc. (CDNA) Affects Rotational Strategy Timing - Stock Traders Daily
CareDx (CDNA) Following Reimbursement Progress Is The Stock Starting To Look Fully Valued - Sahm
Price to earnings forward of CareDx, Inc. – LSX:A118WG - TradingView
Frontier tech research, news & data - MLQ.ai
CareDx to Participate in Upcoming Investor Conferences - AOL.com
Form 4 Caredx Inc For: 7 July By Investing.com - Investing.com Nigeria
Caredx Inc Azioni (CDNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):